{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T11:40:33Z","timestamp":1776685233337,"version":"3.51.2"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,8]]},"DOI":"10.7759\/cureus.48516","type":"journal-article","created":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T19:45:45Z","timestamp":1699472745000},"source":"Crossref","is-referenced-by-count":1,"title":["SOX1 Antibody in a Patient With Serotonin Syndrome"],"prefix":"10.7759","author":[{"given":"Julia","family":"Hoffer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Frem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Alkana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charisse","family":"Chih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio K","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra041867","article-title":"The serotonin syndrome","volume":"352","author":"Boyer EW","year":"2005","unstructured":"Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005, 352:1112-20. 10.1056\/NEJMra041867","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4037\/ccn2017169","article-title":"Drug-induced serotonin syndrome","volume":"37","author":"Bartlett D","year":"2017","unstructured":"Bartlett D. Drug-induced serotonin syndrome. Crit Care Nurse. 2017, 37:49-54. 10.4037\/ccn2017169","journal-title":"Crit Care Nurse"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcg109","article-title":"The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity","volume":"96","author":"Dunkley EJ","year":"2003","unstructured":"Dunkley EJ, Isbister GK, Sibbritt D, Dawson AH, Whyte IM. The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM. 2003, 96:635-42. 10.1093\/qjmed\/hcg109","journal-title":"QJM"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2021.654031","article-title":"SOX transcription factors as important regulators of neuronal and glial differentiation during nervous system development and adult neurogenesis","volume":"14","author":"Stevanovic M","year":"2021","unstructured":"Stevanovic M, Drakulic D, Lazic A, Ninkovic DS, Schwirtlich M, Mojsin M. SOX transcription factors as important regulators of neuronal and glial differentiation during nervous system development and adult neurogenesis. Front Mol Neurosci. 2021, 14:654031. 10.3389\/fnmol.2021.654031","journal-title":"Front Mol Neurosci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000281663.81079.24","article-title":"SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome","volume":"70","author":"Sabater L","year":"2008","unstructured":"Sabater L, Titulaer M, Saiz A, Verschuuren J, G\u00fcre AO, Graus F. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome. Neurology. 2008, 70:924-8. 10.1212\/01.wnl.0000281663.81079.24","journal-title":"Neurology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2009.01.015","article-title":"SOX-1 autoantibodies in patients with paraneoplastic neurological syndromes","volume":"8","author":"Tschernatsch M","year":"2009","unstructured":"Tschernatsch M, Gross O, Kneifel N, Kaps M, Blaes F. SOX-1 autoantibodies in patients with paraneoplastic neurological syndromes. Autoimmun Rev. 2009, 8:549-51. 10.1016\/j.autrev.2009.01.015","journal-title":"Autoimmun Rev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-022-06220-7","article-title":"Coexistence of NMDAR, GAD65, and SOX1 antibody-associated autoimmune encephalitis","volume":"43","author":"Qiao S","year":"2022","unstructured":"Qiao S, Zhou P, Wang ZH, Wu HK, Liu XW. Coexistence of NMDAR, GAD65, and SOX1 antibody-associated autoimmune encephalitis. Neurol Sci. 2022, 43:6125-30. 10.1007\/s10072-022-06220-7","journal-title":"Neurol Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2016.09.002","article-title":"Prevalence of anti-SOX1 reactivity in various neurological disorders","volume":"369","author":"Berger B","year":"2016","unstructured":"Berger B, Dersch R, Ruthardt E, Rasiah C, Rauer S, Stich O. Prevalence of anti-SOX1 reactivity in various neurological disorders. J Neurol Sci. 2016, 369:342-6. 10.1016\/j.jns.2016.09.002","journal-title":"J Neurol Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.607773","article-title":"An Australian state-based cohort study of autoimmune encephalitis cases detailing clinical presentation, investigation results, and response to therapy","volume":"12","author":"Swayne A","year":"2021","unstructured":"Swayne A, Warren N, Prain K, et al.. An Australian state-based cohort study of autoimmune encephalitis cases detailing clinical presentation, investigation results, and response to therapy. Front Neurol. 2021, 12:607773. 10.3389\/fneur.2021.607773","journal-title":"Front Neurol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-020-00967-3","article-title":"Cerebrospinal fluid, antineuronal autoantibody, EEG, and MRI findings from 992 patients with schizophreniform and affective psychosis","volume":"10","author":"Endres D","year":"2020","unstructured":"Endres D, Meixensberger S, Dersch R, et al.. Cerebrospinal fluid, antineuronal autoantibody, EEG, and MRI findings from 992 patients with schizophreniform and affective psychosis. Transl Psychiatry. 2020, 10:279. 10.1038\/s41398-020-00967-3","journal-title":"Transl Psychiatry"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000207486","article-title":"Searching for neuronal antibodies in psychiatric diseases: uncertain findings and implications","volume":"101","author":"Guasp M","year":"2023","unstructured":"Guasp M, Dalmau J. Searching for neuronal antibodies in psychiatric diseases: uncertain findings and implications. Neurology. 2023, 101:656-60. 10.1212\/WNL.0000000000207486","journal-title":"Neurology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1159\/000526425","article-title":"Autoantibodies against central nervous system antigens and the serum levels of IL-32 in patients with schizophrenia","volume":"29","author":"Keshavarz F","year":"2022","unstructured":"Keshavarz F, Soltani M, Mokhtarian K, et al.. Autoantibodies against central nervous system antigens and the serum levels of IL-32 in patients with schizophrenia. Neuroimmunomodulation. 2022, 29:493-9. 10.1159\/000526425","journal-title":"Neuroimmunomodulation"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00769","article-title":"Caveats and pitfalls of SOX1 autoantibody testing with a commercial line blot assay in paraneoplastic neurological investigations","volume":"10","author":"Ruiz-Garc\u00eda R","year":"2019","unstructured":"Ruiz-Garc\u00eda R, Mart\u00ednez-Hern\u00e1ndez E, Garc\u00eda-Ormaechea M, et al.. Caveats and pitfalls of SOX1 autoantibody testing with a commercial line blot assay in paraneoplastic neurological investigations. Front Immunol. 2019, 10:769. 10.3389\/fimmu.2019.00769","journal-title":"Front Immunol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.anndiagpath.2016.09.010","article-title":"False-positive results in diagnostic immunohistochemistry are related to horseradish peroxidase conjugates in commercially available assays","volume":"25","author":"Nuovo G","year":"2016","unstructured":"Nuovo G. False-positive results in diagnostic immunohistochemistry are related to horseradish peroxidase conjugates in commercially available assays. Ann Diagn Pathol. 2016, 25:54-9. 10.1016\/j.anndiagpath.2016.09.010","journal-title":"Ann Diagn Pathol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2006.09.001","article-title":"Autoantibody profiling to identify individuals at risk for systemic lupus erythematosus","volume":"27","author":"Wandstrat AE","year":"2006","unstructured":"Wandstrat AE, Carr-Johnson F, Branch V, et al.. Autoantibody profiling to identify individuals at risk for systemic lupus erythematosus. J Autoimmun. 2006, 27:153-60. 10.1016\/j.jaut.2006.09.001","journal-title":"J Autoimmun"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1176\/appi.neuropsych.13070153","article-title":"High prevalence of antineuronal antibodies in Tunisian psychiatric inpatients","volume":"27","author":"Laadhar L","year":"2015","unstructured":"Laadhar L, Sidhom O, Zitouni M, et al.. High prevalence of antineuronal antibodies in Tunisian psychiatric inpatients. J Neuropsychiatry Clin Neurosci. 2015, 27:54-8. 10.1176\/appi.neuropsych.13070153","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-017-1325-z","article-title":"What is the significance of onconeural antibodies for psychiatric symptomatology? A systematic review","volume":"17","author":"S\u00e6ther SG","year":"2017","unstructured":"S\u00e6ther SG, Schou M, Kondziella D. What is the significance of onconeural antibodies for psychiatric symptomatology? A systematic review. BMC Psychiatry. 2017, 17:161. 10.1186\/s12888-017-1325-z","journal-title":"BMC Psychiatry"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.163.3.521","article-title":"Association of schizophrenia and autoimmune diseases: linkage of Danish national registers","volume":"163","author":"Eaton WW","year":"2006","unstructured":"Eaton WW, Byrne M, Ewald H, Mors O, Chen CY, Agerbo E, Mortensen PB. Association of schizophrenia and autoimmune diseases: linkage of Danish national registers. Am J Psychiatry. 2006, 163:521-8. 10.1176\/appi.ajp.163.3.521","journal-title":"Am J Psychiatry"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(19)30290-1","article-title":"Autoimmune psychosis: an international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin","volume":"7","author":"Pollak TA","year":"2020","unstructured":"Pollak TA, Lennox BR, M\u00fcller S, et al.. Autoimmune psychosis: an international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin. Lancet Psychiatry. 2020, 7:93-108. 10.1016\/S2215-0366(19)30290-1","journal-title":"Lancet Psychiatry"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852923001888","article-title":"IVIG for treatment-resistant psychosis for a child with Turner syndrome","volume":"28","author":"Perdomo M","year":"2023","unstructured":"Perdomo M, Silverman D, Hamilton C. IVIG for treatment-resistant psychosis for a child with Turner syndrome. CNS Spectr. 2023, 28:249. 10.1017\/S1092852923001888","journal-title":"CNS Spectr"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-022-06055-2","article-title":"Expanding the spectrum of SOX1-antibodies in neuropathy: the coexistence of anti-SOX1 and Guillain-Barr\u00e9 syndrome-a case report","volume":"43","author":"Coniglio S","year":"2022","unstructured":"Coniglio S, Turchi G, Giovannini G, Mazzoli M, Meletti S, Vaudano AE. Expanding the spectrum of SOX1-antibodies in neuropathy: the coexistence of anti-SOX1 and Guillain-Barr\u00e9 syndrome-a case report. Neurol Sci. 2022, 43:3979-82. 10.1007\/s10072-022-06055-2","journal-title":"Neurol Sci"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-016-0779-9","article-title":"Screening for onconeural antibodies in neuromyelitis optica spectrum disorders","volume":"17","author":"Berger B","year":"2017","unstructured":"Berger B, Hottenrott T, Rauer S, Stich O. Screening for onconeural antibodies in neuromyelitis optica spectrum disorders. BMC Neurol. 2017, 17:5. 10.1186\/s12883-016-0779-9","journal-title":"BMC Neurol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1159\/000514106","article-title":"Autoimmune movement disorders: a video-based case series of 11 patients","volume":"84","author":"Chouksey A","year":"2021","unstructured":"Chouksey A, Pandey S. Autoimmune movement disorders: a video-based case series of 11 patients. Eur Neurol. 2021, 84:124-8. 10.1159\/000514106","journal-title":"Eur Neurol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-020-04785-9","article-title":"HSV encephalitis triggered anti-NMDAR encephalitis: a case report","volume":"42","author":"Hu S","year":"2021","unstructured":"Hu S, Lan T, Bai R, Jiang S, Cai J, Ren L. HSV encephalitis triggered anti-NMDAR encephalitis: a case report. Neurol Sci. 2021, 42:857-61. 10.1007\/s10072-020-04785-9","journal-title":"Neurol Sci"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.955170","article-title":"Coexistence of anti-SOX1 and anti-GABAB receptor antibodies with paraneoplastic limbic encephalitis presenting with seizures and memory impairment in small cell lung cancer: a case report","volume":"13","author":"Gong S","year":"2022","unstructured":"Gong S, Han Y, He E, Liu M, Fu X, Deng F. Coexistence of anti-SOX1 and anti-GABAB receptor antibodies with paraneoplastic limbic encephalitis presenting with seizures and memory impairment in small cell lung cancer: a case report. Front Immunol. 2022, 13:955170. 10.3389\/fimmu.2022.955170","journal-title":"Front Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/181793-sox1-antibody-in-a-patient-with-serotonin-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:10:21Z","timestamp":1707509421000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/181793-sox1-antibody-in-a-patient-with-serotonin-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,8]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.48516","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,8]]}}}